Whether we're searching for Waldo or our keys in a room of clutter, we tap into a part of the frontal region of the brain when performing visual, goal-related tasks. Some of us do it well, whereas for others it's a bit challenging. One researcher set out to investigate why, and what specifically this part of the brain, called the pre-supplementary motor area, does during searching.
Read moreBiologists blazing new approaches to studying Alzheimer's have made a major finding on combating inflammation linked to the disease. The researchers' discovery about the role of a protein called TOM-1 heralds a shift toward examining the molecular underpinnings of Alzheimer's processes.
Read moreA monthly, 40-minute phone call from a non-clinical professional may suppress or reverse the trajectory of depression so frequently experienced by family members caring for patients with dementia at home, according to a new study.
Read moreIn a new study, researchers reveal that a lifelong dietary regimen of choline holds the potential to prevent Alzheimer's disease (AD).
Read moreA new study now shows that if telomeres change in their length, that change is also reflected in our brain structure.
Read moreResearchers have developed a superior method to describe the very earliest effects that Alzheimer's Disease proteins have on the properties of brain cells.
Read moreA new study has identified 44 genes linked to age-related hearing loss giving a much clearer understanding of how the condition develops and potential treatments.
Read moreThere are an estimated 90 fatalities a year in the UK caused by drivers pulling out into the path of an oncoming motorcycle. New research by psychologists suggests this sort of crash may often be the result of a short-term memory failure rather than the driver not seeing an approaching motorcycle.
Read moreResearchers have found a way to track the formation of soluble amyloid beta peptide aggregates in lab samples. The aggregates are implicated in the onset of Alzheimer's disease.
Read moreResearchers describe a new use of leukemia drug, nilotinib, to treat a subtype of medulloblastoma, a deadly pediatric brain cancer.
Read more